insights_auto
Why is GH down 4.28%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
US$177.38
arrow_downward
-4.28%(-7.93) 1D
ኦክቶ 30, 2:14:24 ከሰዓት ጂ ኤም ቲ-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
US$182.48
High
US$185.64
Low
US$176.92
Mkt. cap
23.80 ቢ
Avg. vol.
1.86 ሚ
Volume
620.64 ሺ
52-wk high
US$191.01
52-wk low
US$74.55
EPS
-US$3.50
Beta
1.58
Shares outstanding
134.20 ሚ
No. of employees
2 ሺ
Open
US$182.48
High
US$185.64
Low
US$176.92
Mkt. cap
23.80 ቢ
Avg. vol.
1.86 ሚ
Volume
620.64 ሺ
52-wk high
US$191.01
52-wk low
US$74.55
EPS
-US$3.50
Beta
1.58
Shares outstanding
134.20 ሚ
No. of employees
2 ሺ
News stories
From web sources and news partners
Investing.com
·
ከ18 ሰዓቶች በፊት
Guardant Health options signal 14% stock move on earnings
Zacks
·
ከ1 ቀን በፊት
Guardant Health (GH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Investing.com
·
ከ3 ቀናት በፊት
BTIG raises Guardant Health stock price target on growth outlook
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2.5 ሺ
Founded2012
HeadquartersPalo Alto, ካሊፎርኒያ, ዩናይትድ ስቴትስ
SectorHealth care provider
Websiteguardanthealth.com